###begin article-title 0
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function
###end article-title 0
###begin p 1
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 572 573 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 637 638 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 671 677 671 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 745 751 745 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 772 778 772 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 986 992 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1245 1251 1245 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1267 1268 1267 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1286 1292 1286 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
B cell lineage acute lymphoblastic leukemia (ALL) arises in virtually all cases from B cell precursors that are arrested at pre-B cell receptor-dependent stages. The Philadelphia chromosome-positive (Ph+) subtype of ALL accounts for 25-30% of cases of adult ALL, has the most unfavorable clinical outcome among all ALL subtypes and is defined by the oncogenic BCR-ABL1 kinase and deletions of the IKAROS gene in >80% of cases. Here, we demonstrate that the pre-B cell receptor functions as a tumor suppressor upstream of IKAROS through induction of cell cycle arrest in Ph+ ALL cells. Pre-B cell receptor-mediated cell cycle arrest in Ph+ ALL cells critically depends on IKAROS function, and is reversed by coexpression of the dominant-negative IKAROS splice variant IK6. IKAROS also promotes tumor suppression through cooperation with downstream molecules of the pre-B cell receptor signaling pathway, even if expression of the pre-B cell receptor itself is compromised. In this case, IKAROS redirects oncogenic BCR-ABL1 tyrosine kinase signaling from SRC kinase-activation to SLP65, which functions as a critical tumor suppressor downstream of the pre-B cell receptor. These findings provide a rationale for the surprisingly high frequency of IKAROS deletions in Ph+ ALL and identify IKAROS-mediated cell cycle exit as the endpoint of an emerging pathway of pre-B cell receptor-mediated tumor suppression.
###end p 1
###begin p 2
###xml 125 144 125 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">Rolink et al., 2000</xref>
###xml 165 182 165 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ig &#956; heavy chain</italic>
###xml 194 198 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 269 275 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 290 295 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGLL1</italic>
###xml 356 376 349 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">van Loo et al., 2007</xref>
###xml 413 414 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 420 421 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 573 589 558 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Guo et al., 2000</xref>
###xml 738 753 723 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Fu et al., 1998</xref>
###xml 755 775 740 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hayashi et al., 2000</xref>
###xml 943 961 928 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Jumaa et al., 1999</xref>
###xml 1397 1417 1370 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Mancini et al., 2005</xref>
###xml 1422 1423 1395 1396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1470 1475 1443 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKZF1</italic>
###xml 1477 1483 1450 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1518 1519 1491 1492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1531 1553 1504 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Mullighan et al., 2008</xref>
###xml 1556 1561 1529 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKZF1</italic>
###xml 1794 1812 1767 1785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Klein et al., 2006</xref>
###xml 1814 1836 1787 1809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Iacobucci et al., 2008</xref>
###xml 1838 1858 1811 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Reynaud et al., 2008</xref>
###xml 1904 1905 1877 1878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1976 1977 1949 1950 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2005 2009 1978 1982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 2031 2049 2004 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Klein et al., 2004</xref>
###xml 2123 2141 2096 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Klein et al., 2004</xref>
###xml 2143 2147 2116 2120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">2006</xref>
###xml 2215 2216 2188 2189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2275 2276 2248 2249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2364 2365 2337 2338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2207 2212 <span type="species:ncbi:9606">human</span>
The pre-B cell receptor promotes differentiation and proliferation signals in B cell precursor cells within the bone marrow (Rolink et al., 2000). It consists of an Ig mu heavy chain (mu chain; IGHM) coupled to the surrogate light chain with its two components, VpreB (VPREB1) and lambda5 (IGLL1), which promote constitutive pre-B cell receptor signaling (van Loo et al., 2007; ). Productive rearrangement of Ig VH to DJH gene segments is a prerequisite for the expression of a functional mu chain, which is linked to the Igalpha and Igbeta transmembrane signaling chains (Guo et al., 2000). The key components of the proximal pre-B cell receptor signaling cascade are assembled and stabilized by the linker protein SLP65 (or BLNK, BASH; Fu et al., 1998; Hayashi et al., 2000; Fig. S1). In the absence of SLP65, the function of the pre-B cell receptor is compromised and SLP65-deficient B cell precursors are arrested at the pre-B cell stage (Jumaa et al., 1999). In virtually all cases, B cell lineage acute lymphoblastic leukemia (ALL) is derived from B cell precursors that are arrested at pre-B cell receptor-dependent stages of development. Among ALL in adults, the Philadelphia chromosome (Ph) encoding the oncogenic BCR-ABL1 tyrosine kinase, represents the most frequent cytogenetic abnormality (approximately25-30% of cases) and defines the ALL subset with the most unfavorable prognosis (Mancini et al., 2005). Ph+ ALL is also characterized by deletions of the IKZF1 (IKAROS) gene that are found in >80% of Ph+ ALL cases (Mullighan et al., 2008). IKZF1 deletions typically lead to the expression of dominant-negative IKAROS variants (e.g., IK6) that are characterized by loss of N-terminal zinc fingers that mediate DNA binding, whereas the C-terminal dimerization domain is retained (Klein et al., 2006; Iacobucci et al., 2008; Reynaud et al., 2008). Based on a previous study of 12 cases of Ph+ ALL, our group described inactivation of the pre-B cell receptor in Ph+ ALL based on nonfunctional IGHM gene rearrangements (Klein et al., 2004) and down-regulation of pre-B cell receptor-related signaling molecules (Klein et al., 2004, 2006). Here, we confirm these observations based on 57 cases of human Ph+ ALL as compared with normal pre-B cells and 54 cases of Ph- ALL and elucidate the mechanism of pre-B cell receptor-mediated tumor suppression in Ph+ ALL.
###end p 2
###begin title 3
RESULTS
###end title 3
###begin title 4
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Ph+ ALL clones are selected against expression of a functional pre-B cell receptor
###end title 4
###begin p 5
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 344 345 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 350 351 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 374 375 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 381 382 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 420 421 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 427 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 529 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 535 536 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 545 546 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 551 552 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 737 741 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 854 858 852 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 981 985 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 1069 1077 1067 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
To investigate the role of the pre-B cell receptor in Ph+ ALL, we studied the configuration of the IGHM locus in sorted normal human B cell precursor cells by single-cell PCR, and in 54 cases of Ph- and 57 cases of Ph+ ALL. The frequency of normal human B cell precursors lacking coding capacity for a mu chain decreased from 41% in pro-B (CD19+ CD34+) to 13% in pre-B (CD19+ VpreB+) and to 12% in immature B cells (CD10+ CD20+). Because pre-B cell receptor selection represents an ongoing process, it is possible that some CD19+ VpreB+ and CD10+ CD20+ cells were viably sorted even though these cells lacked coding capacity for a mu chain and were therefore destined to die. In addition, in some cells, a second productively rearranged IGHM allele may have been missed in our single-cell PCR analysis. Compared with random distribution of nonfunctional IGHM alleles (calculated based on the statistical model described in ), we found evidence for positive selection of functional IGHM alleles in pre-B cells (P = 0.03) and immature B cells (P = 0.01; green asterisks, Fig. 1 A).
###end p 5
###begin p 6
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pre-B cell receptor function in normal human B cell precursors and Ph<sup>+</sup> ALL.</bold>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 706 708 706 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 822 823 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 960 961 960 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1084 1085 1084 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1290 1291 1289 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1454 1455 1453 1454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1520 1521 1519 1520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 977 982 <span type="species:ncbi:9606">human</span>
Pre-B cell receptor function in normal human B cell precursors and Ph+ ALL. The configuration of the Ig heavy chain (IGHM) locus was studied in bone marrow pro-B cells, pre-B cells, immature B cells, 57 cases of Ph+ ALL, and 54 cases of Ph-negative ALL (A). The frequencies of cells/ALL clones lacking a functional IGHM gene rearrangement (light bars) and the total frequency of nonfunctional IGHM alleles in these populations (dark bars) are shown. The expected frequencies of cells/ ALL clones lacking coding capacity for a pre-B cell receptor based on random distribution (Table S1) are indicated as horizontal gray lines. Asterisks denote significant differences from random distribution (P < 0.05). Ca2+ mobilization in response to pre-B cell receptor engagement was studied in normal B and pre-B cells, 7 cases of Ph+ ALL and 10 Ph-negative ALL (B). A metaanalysis of published gene expression data for pre-B cell receptor-related genes in 15 cases of Ph+ ALL and normal human B cell precursors was performed (C, left). P values and false discovery rates (FDR) are indicated. Ph+ ALL cell lines (BV173, Nalm1, SUP-B15, and TOM1) were cultured in the presence or absence of 10 mumol/STI571 (Imatinib) for 16 h and analyzed by Affymetrix U133A2.0 microarrays (C, middle). 22 cases of Ph+ ALL were analyzed by a SNP mapping assay (C, right). The frequency of deletions is given in percent. The frequencies of deletions in our dataset of 22 cases of Ph+ ALL are plotted against the frequencies of deletions found in Ph- ALL (Mullighan et al., 2007).
###end p 6
###begin p 7
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 97 98 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 120 128 120 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 255 263 255 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 379 380 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 409 417 409 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2A-PBX1</italic>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 427 435 427 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TEL-AML1</italic>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 625 633 625 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 31 38 <span type="species:ncbi:9606">patient</span>
In contrast, 47 of 57 (83%) of patient-derived Ph+ ALL cases carried only nonfunctional IGHM VHDJH gene rearrangements (Fig. 1 A and Table S1). Ph+ ALL cases are selected against expression of a functional IGHM gene rearrangement (P = 0.01; red asterisk, Fig. 1 A). Negative selection of pre-B cell receptor expression is specific for Ph+ ALL because in a group of 54 cases of Ph- ALL, including ALL carrying E2A-PBX1 (n = 8), TEL-AML1 (n = 11), or MYC (n = 4) gene rearrangements and ALL with hyperdiploid (n = 18) and normal karyotype (n = 13), no evidence for negative selection against functional IGHM alleles was found (Fig. 1 A).
###end p 7
###begin title 8
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Lack of pre-B cell receptor function in Ph+ ALL cells
###end title 8
###begin p 9
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 418 420 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 475 476 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 488 496 487 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 618 619 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 657 658 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 746 747 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 788 790 785 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 845 853 842 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 939 940 935 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1078 1079 1074 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We next tested whether the pre-B cell receptor is functional in the few cases of Ph+ ALL that harbor at least one productively rearranged IGHM allele. The function of the pre-B cell receptor was studied in 7 Ph+ and 10 Ph- ALL cell lines. As a control, we used bone marrow B cell precursor cells from four healthy donors. Engagement of the pre-B cell receptor using mu chain-specific antibodies resulted in a strong Ca2+ signal in normal pre-B cells, but none of the seven Ph+ ALL cases (Fig. 1 B). Because normal bone marrow B cell precursors were only gated on the pan-B cell antigen CD19, we cannot exclude that IgM+ immature B cells rather than mu chain+ pre-B cells responded to mu chain/IgM engagement. For this reason, we also tested 10 Ph- ALL cases, 7 of which showed a strong Ca2+ signal in response to pre-B cell receptor engagement (Fig. 1 B). We conclude that even in the few cases in which a mu chain can be expressed, the Ph+ ALL cells lack pre-B cell receptor function, indicating that pre-B cell receptor function is compromised in most, if not all, cases of Ph+ ALL.
###end p 9
###begin title 10
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Down-regulation of pre-B cell receptor-related signaling molecules in Ph+ ALL
###end title 10
###begin p 11
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 194 211 194 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Ross et al., 2003</xref>
###xml 249 270 249 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">van Zelm et al., 2005</xref>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYK</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLP65</italic>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGLL1</italic>
###xml 380 386 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 429 434 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD79B</italic>
###xml 465 469 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF4</italic>
###xml 507 508 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 562 570 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 598 599 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 649 657 645 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 827 830 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYK</italic>
###xml 832 837 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLP65</italic>
###xml 839 844 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGLL1</italic>
###xml 846 852 842 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 854 858 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 864 868 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF4</italic>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
To investigate expression levels of pre-B cell receptor-related signaling molecules in human Ph+ ALL cells, we performed a metaanalysis of published gene expression data of 15 cases of Ph+ ALL (Ross et al., 2003) and normal human B cell precursors (van Zelm et al., 2005), as described in . Interestingly, a group of pre-B cell receptor-related genes including SYK, SLP65, IGLL1, VPREB1 (surrogate light chain), IGHM (mu chain), CD79B (Igbeta signaling chain), and IRF4 are consistently down-regulated in Ph+ ALL as compared with normal human B cell precursors (Fig. 1 C, left). Analysis of four Ph+ ALL cell lines (BV173, Nalm1, SUP-B15, and TOM1; Fig. 1 C, middle) that were cultured in the presence or absence of STI571 (Imatinib) showed that inhibition of the BCR-ABL1 kinase restored normal messenger RNA (mRNA) levels of SYK, SLP65, IGLL1, VPREB1, IGHM, and IRF4.
###end p 11
###begin title 12
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Genomic deletions of pre-B cell receptor-related genes in Ph+ ALL
###end title 12
###begin p 13
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nsp</italic>
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGLL1</italic>
###xml 286 289 286 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYK</italic>
###xml 290 296 290 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> SLP65</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD79B</italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> IRF4</italic>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BTLA</italic>
###xml 340 348 340 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 380 386 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGLL1</italic>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX5</italic>
###xml 586 608 586 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Mullighan et al., 2007</xref>
###xml 610 631 610 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Kawamata et al., 2008</xref>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 710 732 710 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Mullighan et al., 2008</xref>
###xml 752 758 752 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 951 957 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 997 998 997 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1027 1028 1027 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1159 1160 1159 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We next studied genomic deletions in the same set of pre-B cell receptor-related genes using the 250 NspI SNP-chip platform and found deletions in at least one of these genes in all 22 Ph+ ALL cases analyzed. We detected VPREB1 and IGLL1 deletions in 5 of 22 cases and deletions in the SYK, SLP65, CD79B, IRF4, and BTLA gene at least once (Fig. 1 C, right). With the exception of VPREB1 and IGLL1, all these deletions were heterozygous, so their functional significance remains to be investigated. Previous studies showed that heterozygous deletions of PAX5 lead to haploinsufficiency (Mullighan et al., 2007; Kawamata et al., 2008) and to the expression of dominant-negative mutants as in the case of IKAROS (Mullighan et al., 2008). Deletions of the VPREB1 gene encoding part of the pre-B cell receptor surrogate light chain were subsequently verified by FISH analysis and quantitative genomic PCR (). 3 monoallelic and 2 biallelic deletions of the VPREB1 locus were identified in 22 cases of Ph+ ALL, but not in any of 22 Ph- ALL cases (P < 0.05). We conclude that deletions in pre-B cell receptor-related genes represent a novel and frequent feature of Ph+ ALL.
###end p 13
###begin title 14
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 72 87 <span type="species:ncbi:10090">transgenic mice</span>
Pre-B cell receptor function during leukemic transformation in BCR-ABL1 transgenic mice
###end title 14
###begin p 15
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 165 189 165 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Heisterkamp et al., 1990</xref>
###xml 295 303 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 555 563 555 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 720 728 720 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 870 878 870 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 984 992 984 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1120 1128 1119 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1239 1247 1238 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1252 1254 1251 1253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1415 1423 1414 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 148 163 <span type="species:ncbi:10090">transgenic mice</span>
###xml 304 319 <span type="species:ncbi:10090">transgenic mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 879 894 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1328 1332 <span type="species:ncbi:10090">mice</span>
###xml 1397 1401 <span type="species:ncbi:10090">mice</span>
To investigate the function of the pre-B cell receptor during progressive leukemic transformation in vivo, we studied B cell precursors in BCR-ABL1 transgenic mice (Heisterkamp et al., 1990) at different stages of malignant transformation. B cell precursors of (a) wild-type littermates and (b) BCR-ABL1 transgenic mice at <60 d of age in the absence of any indication of leukemia (preleukemic), (c) mice with full-blown leukemia (>90 d of age) before and (d) after 7 d of treatment with the BCR-ABL1 kinase inhibitor AMN107 (Nilotinib; ). Interestingly, BCR-ABL1 transgenic pre-B cells represent a normal polyclonal population before the onset of leukemia, but mainly belong to one single clone in full-blown leukemia (Fig. 2 A). Treatment with AMN107 eradicates the dominant leukemia clone and restores a normal polyclonal pre-B cell repertoire. B cell development in BCR-ABL1 transgenic mice with overt leukemia was arrested at a pre-B cell receptor-negative stage of development (Fig. 2 B). As opposed to wild-type and preleukemic B cells, B lymphoid cells in full-blown leukemia did not express Ig mu-heavy chains (Fig. 2 B). Treatment of the leukemic mice with AMN107, however, restored phenotypically normal B cell differentiation (Fig. 2 B). Ca2+ release in response to pre-B cell receptor engagement was compromised in mice with full-blown leukemia, yet restored by treatment of leukemic mice with AMN107 (Fig. 2 C).
###end p 15
###begin p 16
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Progressive leukemic transformation of B cell precursors in <italic>BCR-ABL1</italic> transgenic mice.</bold>
###xml 123 131 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 565 573 564 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 603 611 602 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 69 84 <span type="species:ncbi:10090">transgenic mice</span>
###xml 132 147 <span type="species:ncbi:10090">transgenic mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 574 589 <span type="species:ncbi:10090">transgenic mice</span>
###xml 612 627 <span type="species:ncbi:10090">transgenic mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
Progressive leukemic transformation of B cell precursors in BCR-ABL1 transgenic mice. B cell precursors from wild-type and BCR-ABL1 transgenic mice were analyzed for their clonality using spectratyping of Ig gene rearrangements (A), mu chain expression (B), pre-B cell receptor responsiveness (C), and gene expression pattern (D), and RT-PCR validation (E; three experiments). Data in A-C are representative of results from six independent experiments with at least two mice per group. B cell precursor populations were compared from wild-type animals, preleukemic BCR-ABL1 transgenic mice (age <60 d), BCR-ABL1 transgenic mice with full-blown leukemia (age >90 d), and after treatment of mice with AMN107 (75 mg/kg/d) for 7 d.
###end p 16
###begin p 17
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 376 384 376 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 454 460 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ikaros</italic>
###xml 566 574 566 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 612 620 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 167 182 <span type="species:ncbi:10090">transgenic mice</span>
###xml 385 400 <span type="species:ncbi:10090">transgenic mice</span>
mRNA levels of pre-B cell receptor-related signaling molecules were studied in sorted CD19+ AA4.1+ bone marrow pre-B cell populations from wild-type mice and BCR-ABL1 transgenic mice before and after leukemic transformation and after 7 d of treatment with AMN107. Although mRNA levels for most pre-B cell receptor-related molecules were similar in wild-type and "preleukemic" BCR-ABL1 transgenic mice, a subset of these genes (including Ighm, Slp65, and Ikaros) was substantially down-regulated upon full leukemic transformation, as determined by GeneChip analysis (Fig. 2 D) and quantitative RT-PCR validation (Fig. 2 E). Together, these results suggest that active signaling from a functional pre-B cell receptor and the BCR-ABL1 kinase are mutually exclusive.
###end p 17
###begin title 18
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
Reconstitution of pre-B cell receptor signaling in Slp65-/- and Ighm-/-BCR-ABL1-transformed pre-B ALL cells suppresses leukemic growth
###end title 18
###begin p 19
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 312 318 312 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 398 419 398 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Flemming et al., 2003</xref>
###xml 548 553 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 568 576 566 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 589 594 587 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 594 597 592 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 637 645 635 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 661 669 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 671 696 669 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Meixlsperger et al., 2007</xref>
###xml 751 756 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 771 779 769 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 873 874 871 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 884 889 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLP65</italic>
###xml 902 920 900 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Jumaa et al., 2003</xref>
###xml 969 977 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 865 870 <span type="species:ncbi:9606">human</span>
To test this hypothesis in a formal experiment, we reconstituted pre-B cell receptor signaling in BCR-ABL1-transformed bone marrow B cell precursors from mice carrying pre-B cell receptor defects. To this end, we transformed bone marrow B cell precursors from Slp65-/- and Ighm-/- mice with retroviral BCR-ABL1 (Fig. 3). These mice lack expression of the pre-B cell receptor linker molecule Slp65 (Flemming et al., 2003) or fail to express a mu chain because of deletion of the Cmu transmembrane domain. In one set of experiments, we reconstituted Slp65 expression in BCR-ABL1-transformed Slp65-/- pre-B ALL cells either constitutively (Fig. 3 A) or inducibly (Fig. 3 B; Meixlsperger et al., 2007). In both systems, we observed selective depletion of Slp65-reconstituted BCR-ABL1 ALL cells within 9 d after Slp65 reconstitution. We also studied one case of primary human Ph+ ALL with SLP65 deficiency (Jumaa et al., 2003), reconstitution of which had a similar effect (Fig. 3 C).
###end p 19
###begin p 20
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 114 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reconstitution of Slp65 deficiency in <italic>BCR-ABL1</italic> ALL cells suppresses leukemic growth <italic>BCR-ABL1</italic>&#8211;transformed <italic>Slp65</italic><sup>&#8722;/&#8722;</sup>.</bold>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 468 471 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 471 479 471 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 719 720 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 942 950 941 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 963 968 962 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 968 971 967 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1360 1361 1359 1360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1365 1366 1364 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 679 684 <span type="species:ncbi:9606">human</span>
###xml 1158 1162 <span type="species:ncbi:10090">mice</span>
Reconstitution of Slp65 deficiency in BCR-ABL1 ALL cells suppresses leukemic growth BCR-ABL1-transformed Slp65-/-. ALL cells were reconstituted with Slp65/GFP or a GFP empty vector control (A; single measurements in three independent experiments). For inducible Slp65 reconstitution, we fused Slp65 to the estrogen receptor ligand-binding domain (ERT2). Either ERT2 fused to the N terminus of Slp65 (ERT2-Slp65/GFP) or ERT2 alone (ERT2/GFP) were expressed in the Slp65-/-BCR-ABL1-transformed ALL cells and activated by addition of 1 mumol/l 4-hydroxy-tamoxifen (OHT) using ethanol (EtOH) as vehicle control (B; triplicate measurements, the experiment was repeated once). Primary human leukemia cells from one case of Ph+ ALL cells lacking expression of SLP65 were cultured on OP9 stroma in the presence of IL-7 and transduced with SLP65/GFP or a GFP empty vector control (three independent transductions) and monitored by flow cytometry (C). BCR-ABL1-transformed Slp65-/- ALL cells were labeled by lentiviral firefly luciferase, transduced with retroviral vectors encoding either Slp65/GFP or GFP alone and injected into five sublethally irradiated NOD/SCID mice per group. Engraftment and leukemic growth was monitored by luciferase-bioimaging (D; experiment repeated once). The blue scale bar in (D) corresponds to 1 cm in length. Leukemic infiltration (CD19+ GFP+) of bone marrow, spleen, and peripheral blood (three independent experiments) was documented by flow cytometry (E; representative data from two experiments).
###end p 20
###begin p 21
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 281 282 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 397 405 397 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 719 727 719 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 898 903 898 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 927 930 927 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 930 938 930 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1105 1113 1093 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
###xml 1278 1296 1266 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Jumaa et al., 2003</xref>
###xml 1298 1306 1286 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1366 1374 1354 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 1261 1266 <span type="species:ncbi:9606">human</span>
###xml 1387 1392 <span type="species:ncbi:10090">mouse</span>
To investigate the consequences of pre-B cell receptor reconstitution in vivo, Slp65-/-BCR-ABL1-transformed pre-B cells were labeled with lentiviral firefly luciferase and transduced with Slp65-GFP or GFP alone. NOD/SCID mice were sublethally irradiated and injected with Slp65-GFP+ or GFP+ ALL cells. Starting 1 wk after tail vein injection, engraftment was monitored by bioluminescence imaging (Fig. 3 D). As opposed to mice injected with Slp65-GFP-transduced leukemia cells, the mice that were inoculated with GFP-transduced leukemia cells showed signs of terminal disease and weight loss 36 d after injection. At this time, all mice were sacrificed; mice injected with GFP-transduced, but not Slp65-GFP-transduced, BCR-ABL1 ALL cells showed increased white blood cell counts and expansion of peripheral blood B cell precursors (). Compared with GFP-transduced leukemia cells, reconstitution of Slp65 expression in the Slp65-/-BCR-ABL1-transformed pre-B ALL cells reduced the leukemia cell burden by approximately15-fold in the bone marrow, 5-fold in the spleen, and >100-fold in the peripheral blood (Fig. 3 E and Table S3). We conclude that inactivation of the pre-B cell receptor-related signaling molecule Slp65 not only represents a frequent feature in human ALL cells (Jumaa et al., 2003; Fig. 1 C), but also represents a requirement for leukemic growth of BCR-ABL1-transformed mouse pre-B cells in vivo.
###end p 21
###begin p 22
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 138 142 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 219 220 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 237 238 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 287 295 285 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 336 337 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 374 375 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 470 471 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 491 495 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 648 649 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 661 669 656 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 785 786 780 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 462 467 <span type="species:ncbi:9606">human</span>
###xml 640 645 <span type="species:ncbi:9606">human</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
In an alternative approach, we transduced BCR-ABL1-transformed Ighm-/- ALL cells with a retroviral vector encoding a functional mu chain (Ighm) together with CD8 or CD8 alone (control). Enrichment or depletion of mu/CD8+ cells versus CD8+ cells was monitored for 10 d by flow cytometry (Fig. 4 A). We observed progressive loss of mu/CD8+ cells, whereas the population of CD8+ cells remained stable. We next reconstituted mu chain expression in a primary case of human Ph+ ALL, in which both IGHM alleles were nonproductively rearranged. Also in this case, reconstitution of mu chain expression rapidly suppressed leukemic growth in primary human Ph+ ALL cells (Fig. 4 B). We conclude that reconstitution of pre-B cell receptor signaling effectively prevents leukemic growth of human Ph+ ALL.
###end p 22
###begin p 23
###xml 70 78 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 91 95 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 95 98 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 99 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reconstitution of &#956; chain expression results in leukemia suppression <italic>BCR-ABL1</italic>&#8211;transformed <italic>Ighm</italic><sup>&#8722;/&#8722;</sup>.</bold>
###xml 258 259 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 271 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 356 357 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 589 597 584 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 801 802 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 823 824 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 348 353 <span type="species:ncbi:9606">human</span>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
Reconstitution of mu chain expression results in leukemia suppression BCR-ABL1-transformed Ighm-/-. ALL cells were transduced with retroviral expression vectors encoding either CD8 alone or CD8 with a functional mu heavy chain. Enrichment or depletion of CD8+ and mu/CD8+ cells was monitored over 10 d (A; three independent transductions). Primary human Ph+ ALL cells lacking coding capacity for expression of a mu chain were cultured on OP9 stroma in the presence of IL-7 and transduced with mu chain/CD8 or CD8 alone and monitored by flow cytometry (B; three independent transductions). BCR-ABL1 transgenic mouse B cell lineage leukemia cells lacking mu chain expression were transduced with retroviral expression vectors encoding either CD8 alone or CD8/mu chain (C and D). Percentages of Annexin V+ and propidium iodide+ cells were determined after 2 and 5 d of transduction and means of three experiments are indicated in (D).
###end p 23
###begin title 24
Mechanism of pre-B cell receptor-induced suppression of leukemic growth
###end title 24
###begin p 25
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 215 230 215 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, C and D</xref>
###xml 236 242 236 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
###xml 293 301 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 431 432 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 440 441 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 449 464 446 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, C and D</xref>
###xml 610 625 606 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, C and D</xref>
###xml 691 692 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 700 701 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 952 969 946 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Hess et al., 2001</xref>
###xml 1036 1044 1030 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1089 1093 1083 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 1093 1096 1087 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1174 1191 1167 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Hess et al., 2001</xref>
###xml 1215 1223 1208 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1225 1229 1218 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 1229 1232 1222 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1374 1382 1365 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1433 1437 1423 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 1437 1440 1427 1430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1465 1473 1454 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1503 1511 1492 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1702 1719 1689 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Hess et al., 2001</xref>
###xml 1721 1729 1708 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1753 1761 1740 1748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1778 1781 1765 1768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1919 1934 1904 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, B and C</xref>
###xml 1157 1172 <span type="species:ncbi:10090">transgenic mice</span>
To clarify how reconstitution of pre-B cell receptor signaling in Ph+ ALL cells suppresses leukemic growth, we tested the effect of pre-B cell receptor signaling on the survival and proliferation of leukemia cells (Fig. 4, C and D, and Fig. 5). To this end, we reconstituted mu chain-negative BCR-ABL1 leukemia cells either with a mu chain/CD8 expression vector or a CD8 empty vector control and measured cell death in mu chain/CD8+ and CD8+ cells (Fig. 4, C and D). mu Chain reconstitution resulted in a modest induction of cell death, and most of the leukemia cells remained viable 5 d after reconstitution (Fig. 4, C and D). It should be noted that this analysis was gated on mu chain/CD8+ and CD8+ cells, which underestimates the degree of cell death induction because dying cells lose mu chain/CD8 or CD8 surface expression. In a complementary system that allows for inducible activation of pre-B cell receptor signaling in all B cell precursors (Hess et al., 2001), we further studied the role of pre-B cell receptor signaling in BCR-ABL1 leukemia cells. Such B cell precursors from Rag2-/- tetracycline (Tet)-controlled transactivator (tTA)/mu chain transgenic mice (Hess et al., 2001) were transformed with BCR-ABL1. Rag2-/- tTA/mu chain transgenic B cell precursors are unable to endogenously express a pre-B cell receptor, but carry a Tet-inducible mu chain gene (Fig. 5 A). We verified induction of mu chain expression in Rag2-/- tTA/mu chain transgenic BCR-ABL1 ALL cells by flow cytometry (Fig. 5 A). Because mu chain expression in this system is regulated by endogenous transcriptional control elements, levels of mu chain expression are low, as typically observed in normal pre-B cells (Hess et al., 2001; Fig. 5 A). Withdrawal of Tet in BCR-ABL1-transformed Rag2-/- tTA/mu chain transgenic B cell precursors resulted in mu chain expression and subsequent suppression of leukemic growth in cell culture (Fig. 5, B and C), indicating that the tumor suppressor function of the pre-B cell receptor involves induction of cell cycle exit.
###end p 25
###begin p 26
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reconstitution of pre&#8211;B cell receptor signaling in <italic>BCR-ABL1</italic> ALL cells induces cell cycle arrest.</bold>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 530 538 524 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 117 132 <span type="species:ncbi:10090">transgenic mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
Reconstitution of pre-B cell receptor signaling in BCR-ABL1 ALL cells induces cell cycle arrest.Rag2-/- tTA/mu chain transgenic mice are unable to express an endogenous mu chain but carry a functionally prerearranged mu chain under control of Tet operator (tetO) sequences. These mice express a tTA under control of endogenous mu chain regulatory elements and withdrawal of Tet results in activation of mu chain expression (A; routinely performed quality control). The effect of Tet-inducible activation of mu chain expression in BCR-ABL1-transformed ALL cells on leukemic growth was measured in a detailed cell cycle analysis (B-C). Percentages of cells in G0/G1, S and G2/M phases of the cell cycle were calculated and means of three experiments are indicated in C.
###end p 26
###begin title 27
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
IKAROS function is required for the ability of the pre-B cell receptor to induce cell cycle arrest in Ph+ ALL cells
###end title 27
###begin p 28
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 289 295 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 343 364 343 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Thompson et al., 2007</xref>
###xml 366 381 366 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Ma et al., 2008</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKZF1</italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 550 572 550 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Mullighan et al., 2008</xref>
###xml 638 659 638 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Thompson et al., 2007</xref>
###xml 661 676 661 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Ma et al., 2008</xref>
###xml 776 782 776 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 808 816 808 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 905 913 905 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 948 963 948 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, B and C</xref>
###xml 969 984 969 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, B and C</xref>
###xml 1010 1016 1010 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1103 1111 1103 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1170 1176 1170 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1178 1200 1178 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Iacobucci et al., 2008</xref>
###xml 1202 1220 1202 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Klein et al., 2006</xref>
###xml 1222 1242 1222 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Reynaud et al., 2008</xref>
###xml 1280 1286 1280 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1351 1357 1351 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1359 1379 1359 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Reynaud et al., 2008</xref>
###xml 1439 1440 1439 1440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1446 1464 1446 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Klein et al., 2006</xref>
###xml 1466 1488 1466 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Iacobucci et al., 2008</xref>
###xml 1490 1512 1490 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Mullighan et al., 2008</xref>
###xml 1585 1593 1585 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1606 1610 1606 1610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 1610 1613 1610 1613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1758 1769 1757 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, B&#8211;D</xref>
###xml 1908 1916 1907 1915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 2046 2054 2045 2053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 D</xref>
###xml 2149 2155 2148 2154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 2237 2264 2236 2263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">G&#243;mez-del Arco et al., 2004</xref>
###xml 2266 2287 2265 2286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Kathrein et al., 2005</xref>
###xml 2391 2397 2390 2396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN1B</italic>
###xml 2399 2420 2398 2419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Kathrein et al., 2005</xref>
###xml 2501 2507 2500 2506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 2576 2591 2575 2590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, B and C</xref>
We then focused our investigation of the mechanism of pre-B cell receptor-induced leukemia-suppression on the IKAROS transcription factor based on the following rationale. Two recent studies showed that pre-B cell receptor signaling in normal B cell precursors results in up-regulation of IKAROS, which subsequently induces cell cycle arrest (Thompson et al., 2007; Ma et al., 2008). In addition, a recent landmark study demonstrated that deletions of the IKZF1 (IKAROS) gene represents a defining feature of Ph+ ALL (deletions in >80% of the cases; Mullighan et al., 2008). Validation by quantitative RT-PCR confirmed previous findings (Thompson et al., 2007; Ma et al., 2008) that inducible pre-B cell receptor activation resulted in a 6-8-fold up-regulation of full-length IKAROS mRNA levels within 24 h (Fig. 6 A). Within 42 h after induction of pre-B cell receptor expression, close to 70% of viable BCR-ABL1 ALL cells were arrested in G0/G1 (Fig. 5, B and C, and Fig. 6, B and C). To investigate whether IKAROS function is required for pre-B cell receptor-induced cell cycle arrest, we transduced BCR-ABL1 ALL cells with IK6, a dominant-negative splice variant of IKAROS (Iacobucci et al., 2008; Klein et al., 2006; Reynaud et al., 2008). The IK6 splice variant neutralizes IKAROS function by forming nonfunctional heterodimers with full-length IKAROS (Reynaud et al., 2008) and is abundantly expressed in most if not all cases of Ph+ ALL (Klein et al., 2006; Iacobucci et al., 2008; Mullighan et al., 2008). To test this hypothesis, pre-B cell receptor signaling was induced in BCR-ABL1-transformed Rag2-/- tTA/mu chain transgenic ALL cells that were transduced with the dominant-negative IK6 splice variant (IK6/GFP) or an empty vector control (GFP; Fig. 6, B-D). Whereas IK6/GFP-overexpression did not confer a significant growth advantage over GFP background levels in pre-B cell receptor-negative BCR-ABL1-transformed ALL cells, pre-B cell receptor induction resulted in an up to 25-fold increase of IK6/GFP-transduced leukemia cells (Fig. 6 D; a 5-fold increase was measured in one repeat experiment). Previous studies demonstrated that IKAROS negatively regulates the G1-S phase transition of the cell cycle in pre-B cells (Gomez-del Arco et al., 2004; Kathrein et al., 2005), mainly through histone H3 acetylation and up-regulation of negative cell cycle regulators, including CDKN1B (Kathrein et al., 2005; Fig. S1). Consistent with these findings, we observed that pre-B cell receptor/IKAROS-induced cell cycle arrest can be reversed by dominant-negative IK6 (Fig. 6, B and C).
###end p 28
###begin p 29
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pre-B cell receptor&#8211;mediated suppression of leukemic growth requires IKAROS function.</bold>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ikaros</italic>
###xml 194 202 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 843 844 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 855 856 853 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Pre-B cell receptor-mediated suppression of leukemic growth requires IKAROS function. mRNA levels of Ikaros after mu chain induction were measured by quantitative RT-PCR (A; three experiments). BCR-ABL1-transformed ALL cells were retrovirally transduced with the dominant-negative IKAROS splice variant IK6/GFP or a GFP empty vector control (B-D). Leukemia cells transduced with IK6/GFP (+IK6) or an empty vector control (-IK6) were studied in the presence or absence of pre-B cell receptor activation (+/- mu chain). IK6/GFP- and GFP-transduced leukemia cells were subjected to cell cycle analysis in the presence or absence of inducible pre-B cell receptor signaling (B-D). The percentages of cells in G0/G1, S and G2/M phase are indicated and means of three experiments are indicated in C. In D, the relative increase or decrease of IK6/GFP+ versus GFP+ leukemia cells in the presence or absence of pre-B cell receptor activation (+/- mu chain) was measured. The experiment was repeated once.
###end p 29
###begin title 30
IKAROS cooperates with SLP65 as tumor suppressor even in the absence of a pre-B cell receptor
###end title 30
###begin p 31
###xml 3 9 3 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKZF1</italic>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 398 399 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 437 443 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 445 451 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 451 454 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 528 534 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 536 542 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 542 546 541 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/DN</sup>
###xml 575 581 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 693 699 692 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 714 720 713 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 720 724 719 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/DN</sup>
###xml 735 741 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 741 744 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 747 748 746 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 833 839 831 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 839 843 837 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/DN</sup>
###xml 848 854 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 854 858 852 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/DN</sup>
###xml 861 862 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 948 956 946 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 999 1005 997 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1066 1067 1064 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1079 1087 1077 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 1216 1222 1214 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1319 1320 1317 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1391 1397 1389 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1552 1553 1550 1551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1588 1589 1586 1587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1611 1619 1609 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 1662 1670 1660 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1849 1857 1847 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 390 395 <span type="species:ncbi:9606">human</span>
If IKAROS function was indeed required for the ability of the pre-B cell receptor to induce cell cycle arrest in Ph+ ALL, one would expect that presence or absence of IKAROS (IKZF1) deletions in Ph+ ALL predicts sensitivity of these leukemia clones to reconstitution of pre-B cell receptor signaling. We reconstituted pre-B cell receptor signaling (SLP65 and mu chain) in three established human Ph+ ALL clones carrying either wild-type IKAROS (IKAROS+/+), a heterozygous deletion leading to the expression of dominant-negative IKAROS (IKAROS+/DN), or biallelic deletions of IKAROS (large genomic deletion at 7p12 on one allele, and a small deletion leading to expression of dominant-negative IKAROS on the other (IKAROS-/DN). Whereas IKAROS+/+ Ph+ ALL cells are sensitive to pre-B cell receptor reconstitution (SLP65 and mu chain), IKAROS+/DN and IKAROS-/DN Ph+ ALL cells are largely resistant to pre-B cell receptor-induced leukemia suppression (Fig. 7 A). Retroviral expression of the functional IKAROS form IK1, however, induced cell cycle arrest in all three Ph+ ALL cases (Fig. 7 A), even though leukemia cells in none of these cases expressed a functional pre-B cell receptor. These findings demonstrate that IKAROS function is required for pre-B cell receptor-mediated cell cycle arrest in pre-B cell-derived Ph+ ALL cells. However, these observations also raise the question of how IKAROS can function as a tumor suppressor downstream of the pre-B cell receptor, if pre-B cell receptor signaling is inactivated in most, if not all, cases of Ph+ ALL. Although none of the three Ph+ ALL cases studied in Fig. 7 A express a functional pre-B cell receptor (Fig. 1 B), overexpression of the pre-B cell receptor downstream molecule SLP65 was sufficient to induce leukemia suppression, unless IKAROS function was compromised by genomic deletions (Fig. 7 A).
###end p 31
###begin p 32
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 147 0 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reconstitution of IKAROS expression in Ph<sup>+</sup> ALL cells results in BCR-ABL1-mediated activation of SLP65 even in the absence of a pre&#8211;B cell receptor.</bold>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 192 197 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLP65</italic>
###xml 203 209 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 266 272 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 307 308 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 316 317 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 509 510 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 518 519 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 628 629 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 780 781 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1348 1351 1345 1348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1461 1464 1458 1461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
Reconstitution of IKAROS expression in Ph+ ALL cells results in BCR-ABL1-mediated activation of SLP65 even in the absence of a pre-B cell receptor. Genotype and expression of IGHM (mu chain), SLP65, and IKAROS (both functional IK1 and dominant-negative IK6 forms of IKAROS) were studied in three cases of Ph+ ALL. Ph+ ALL cells were transduced once in each case with retroviral vectors encoding SLP65/GFP, IKAROS (IK1)/GFP and mu chain/CD8 or GFP- and CD8-empty vector controls. Enrichment or depletion of GFP+ and CD8+ cells was monitored by flow cytometry (A; three cases were studied). IKAROS-deficient leukemia cells from Ph+ ALL cases 1 and 2 were transduced with a retroviral expression vector for IKAROS (IK1)/GFP and a GFP empty vector control. 2 d after transduction, GFP+ cells were sorted and cultured in the presence or absence of 10 mumol/liter Imatinib for 12 h (B). Protein lysates from these cells were then subjected to Western blot analysis using antibodies against the SRC family kinase LYN, activated SRC kinases (including LYN) that are phosphorylated at Y416, the ubiquitin-ligase CBL, activated CBL phosphorylated at Y731, SLP65, and activated SLP65 phosphorylated at Y96. Antibodies against EIF4E were used as a loading control. Experiments on two cases were performed. In (C), pre-B cells isolated from bone marrow of Slp65-/- mice were transformed by a retrovirus encoding BCR-ABL1/Neo. In three experiments, BCR-ABL1-transformed Slp65-/- ALL cells were reconstituted with retroviral expression vectors encoding wild-type SLP65/GFP or the mutant SLP65Y96F/GFP or transduced with a GFP empty vector control (C).
###end p 32
###begin title 33
IKAROS redirects BCR-ABL1-mediated SRC-kinase activation to SLP65, a tumor suppressor downstream of the pre-B cell receptor
###end title 33
###begin p 34
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 400 408 400 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 504 505 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 679 680 679 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 843 864 843 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
To elucidate how IKAROS intersects signaling from the pre-B cell receptor downstream molecules (e.g., SLP65), we studied how IKAROS reconstitution in IKAROS/pre-B cell receptor double-deficient leukemia cells affects the activity of pre-B cell receptor downstream molecules (Fig. 7 B). Unlike other subtypes of ALL, Ph+ ALL is driven by a constitutively active tyrosine kinase that is encoded by the BCR-ABL1 oncogene. Therefore, tyrosine phosphorylation of pre-B cell receptor downstream molecules in Ph+ ALL is not necessarily initiated from the pre-B cell receptor and may also originate from the oncogenic BCR-ABL1 kinase. Indeed, the oncogenic BCR-ABL1 tyrosine kinase in Ph+ ALL phosphorylates downstream signaling components of the pre-B cell receptor, thereby mimicking survival and proliferation signals from the pre-B cell receptor (Feldhahn et al., 2005).
###end p 34
###begin p 35
###xml 74 89 74 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 91 112 91 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ptasznik et al., 2004</xref>
###xml 125 140 125 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 148 169 148 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">B&#228;ckesj&#246; et al., 2002</xref>
###xml 171 192 171 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
###xml 204 224 204 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Sattler et al., 2002</xref>
###xml 441 459 437 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Saijo et al., 2003</xref>
###xml 461 490 457 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Hendriks and Kersseboom, 2006</xref>
###xml 603 632 599 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Hendriks and Kersseboom, 2006</xref>
###xml 634 656 630 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Sprangers et al., 2006</xref>
###xml 792 810 784 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Saijo et al., 2003</xref>
###xml 909 930 901 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Flemming et al., 2003</xref>
###xml 1027 1045 1019 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Cheng et al., 1995</xref>
###xml 1047 1065 1039 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Jumaa et al., 1999</xref>
###xml 1067 1088 1059 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Flemming et al., 2003</xref>
###xml 1287 1309 1279 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Ota and Samelson, 1997</xref>
###xml 1391 1406 1383 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Fu et al., 1998</xref>
###xml 1506 1523 1498 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Song et al., 2007</xref>
###xml 1548 1569 1540 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Flemming et al., 2003</xref>
###xml 1571 1591 1563 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Hayashi et al., 2003</xref>
###xml 1608 1609 1600 1601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1711 1726 1703 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 1728 1749 1720 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ptasznik et al., 2004</xref>
###xml 1751 1772 1743 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
###xml 1774 1782 1766 1774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 1850 1851 1842 1843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1863 1878 1855 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 1880 1901 1872 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ptasznik et al., 2004</xref>
###xml 1978 1979 1970 1971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1985 1993 1977 1985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 2084 2094 2076 2086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, 7A</xref>
As shown by us and others, the pre-B cell receptor-related molecules LYN (Hu et al., 2004; Ptasznik et al., 2004), HCK, FGR (Hu et al., 2004), BTK (Backesjo et al., 2002; Feldhahn et al., 2005), and CBL (Sattler et al., 2002) are all tyrosine phosphorylated by BCR-ABL1. These molecules belong to the SRC kinase pathway downstream of the pre-B cell receptor, which mainly promotes survival and proliferation through activation of NF-kappaB (Saijo et al., 2003; Hendriks and Kersseboom, 2006). SRC kinase signaling is distinct from proximal pre-B cell receptor signaling components (e.g., SYK and SLP65; Hendriks and Kersseboom, 2006; Sprangers et al., 2006). For instance, SRC kinases, but not SYK and SLP65, are required for pre-B cell proliferation and NF-kappaB activation in pre-B cells (Saijo et al., 2003). Likewise, SRC kinase-driven pre-B cell proliferation is even increased in the absence of SLP65 (Flemming et al., 2003). Conversely, pre-B cell differentiation depends on SYK/SLP65, but not on SRC kinase signaling (Cheng et al., 1995; Jumaa et al., 1999; Flemming et al., 2003). SRC kinase and SYK/SLP65-dependent pathways intersect at the level of the ubiquitin ligase CBL. SRC kinases, including LYN, activate CBL, which then ubiquitinates SYK for proteasomal degradation (Ota and Samelson, 1997). Because activation of SLP65 through phosphorylation at SLP65-Y96 requires SYK (Fu et al., 1998), SRC kinase/CBL-induced degradation of SYK compromises SLP65-mediated pre-B cell differentiation (Song et al., 2007) and tumor suppression (Flemming et al., 2003; Hayashi et al., 2003; Fig. S1). In Ph+ ALL, LYN, HCK, FGR, BTK, and CBL are all tyrosine-phosphorylated by BCR-ABL1, but not SYK and SLP65 (Hu et al., 2004; Ptasznik et al., 2004; Feldhahn et al., 2005; Fig. 7 B). Whereas the SRC kinase pathway is critical for the survival of Ph+ ALL cells (Hu et al., 2004; Ptasznik et al., 2004), SYK and SLP65 are frequently down-regulated and occasionally deleted in Ph+ ALL (Fig. 1 C), and SLP65 functions as a potent tumor suppressor downstream of the pre-B cell receptor (Fig. 3, 7A).
###end p 35
###begin p 36
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 189 206 189 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Nera et al., 2006</xref>
###xml 450 467 450 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Nera et al., 2006</xref>
###xml 543 544 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 636 651 636 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 653 674 653 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ptasznik et al., 2004</xref>
###xml 676 697 676 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
###xml 744 765 744 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
###xml 770 778 770 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 956 957 955 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 969 977 968 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 1483 1491 1482 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 1715 1736 1714 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Nakayama et al., 2009</xref>
###xml 1805 1824 1804 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Danial et al., 1995</xref>
###xml 1962 1983 1961 1982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Nakayama et al., 2009</xref>
###xml 2207 2215 2206 2214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 1264 1271 <span type="species:ncbi:9031">chicken</span>
Notably, a recent study demonstrated the ability of IKAROS to redirect B cell receptor signaling in DT40 B cell lymphoma from preferential tyrosine phosphorylation of LYN/CBL to SYK/SLP65 (Nera et al., 2006). Whereas LYN/CBL (at the expense of SYK/SLP65) are the main substrates of B cell receptor-induced phosphorylation in IKAROS-deficient DT40 B cell lymphoma, reconstitution of IKAROS reinstates SYK/SLP65 signaling and dephosphorylates LYN/CBL (Nera et al., 2006). For this reason, we examined whether IKAROS can play a similar role in Ph+ ALL, where BCR-ABL1 phosphorylates LYN, CBL and other molecules of the SRC kinase pathway (Hu et al., 2004; Ptasznik et al., 2004; Feldhahn et al., 2005), but not SYK and the tumor suppressor SLP65 (Feldhahn et al., 2005 and Fig. 7 B). To this end, we studied the effect of IKAROS-reconstitution on protein expression and tyrosine phosphorylation of LYN/CBL and SLP65 in two IKAROS-/mu chain double-deficient Ph+ ALL cases (Fig. 7 B). IKAROS reconstitution (IK1) had no significant effect on global protein levels of LYN, CBL, and SLP65. However, tyrosine phosphorylation of SRC family kinases (including LYN) at Y416 and CBL at Y731 was substantially reduced upon IKAROS reconstitution, as previously observed in DT40 chicken B cells. In contrast, IKAROS reconstitution resulted in de novo tyrosine phosphorylation of the tumor suppressor SLP65 at Y96. This phosphorylation event was sensitive to BCR-ABL1 kinase inhibition by Imatinib (Fig. 7 B), suggesting that oncogenic BCR-ABL1 kinase activity is indeed redirected to SLP65-Y96. Importantly, a recent study demonstrated that Y96 of SLP65 is crucial for the ability of SLP65 to bind and, hence, inhibit JAK3-STAT5 (Nakayama et al., 2009), a pathway that is also activated in oncogenic BCR-ABL1 signaling (Danial et al., 1995). Inhibition of JAK3-STAT5 signaling through interaction with SLP65 Y96 leads to activation of p27 (CDKN1B) and rapid cell cycle arrest (Nakayama et al., 2009). Consistent with a tumor suppressor pathway that requires interaction of SLP65-Y96 with JAK3-STAT5 proteins, we observed that SLP65-Y96F, in contrast to wild-type SLP65, failed to suppress BCR-ABL1-driven leukemic growth (Fig. 7 C).
###end p 36
###begin title 37
DISCUSSION
###end title 37
###begin p 38
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 119 137 119 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Klein et al., 2004</xref>
###xml 206 224 206 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Klein et al., 2004</xref>
###xml 226 244 226 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Klein et al., 2006</xref>
###xml 298 299 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Previous work by our group showed that leukemia cells in Ph+ ALL often lack coding capacity for a pre-B cell receptor (Klein et al., 2004) and down-regulate pre-B cell receptor-related signaling molecules (Klein et al., 2004; Klein et al., 2006). These findings suggested that leukemia clones in Ph+ ALL either bypass pre-B cell receptor selection or are even selected against expression of a pre-B cell receptor.
###end p 38
###begin p 39
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 165 171 165 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
###xml 278 284 277 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 297 303 296 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 381 387 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 409 415 408 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 420 426 419 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7</xref>
###xml 555 556 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 562 568 561 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 600 606 599 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 751 752 749 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 777 778 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 880 902 878 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Mullighan et al., 2008</xref>
###xml 927 928 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1108 1123 1106 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 1125 1146 1123 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ptasznik et al., 2004</xref>
###xml 1148 1169 1146 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
###xml 1222 1223 1220 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1324 1330 1322 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 1453 1461 1451 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 1593 1599 1590 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKAROS</italic>
###xml 1637 1638 1634 1635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1878 1879 1875 1876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2214 2235 2210 2231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Nakayama et al., 2009</xref>
###xml 2299 2305 2295 2301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 2324 2351 2320 2347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">G&#243;mez-del Arco et al., 2004</xref>
###xml 2353 2374 2349 2370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Kathrein et al., 2005</xref>
###xml 2721 2736 2717 2732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 2738 2759 2734 2755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ptasznik et al., 2004</xref>
###xml 2767 2788 2763 2784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
###xml 2806 2833 2802 2829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Ilaria and Van Etten., 1996</xref>
###xml 2880 2906 2876 2902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Ilaria and Van Etten, 1996</xref>
###xml 2908 2923 2904 2919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Hu et al., 2004</xref>
###xml 2925 2946 2921 2942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Ptasznik et al., 2004</xref>
###xml 2948 2969 2944 2965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Feldhahn et al., 2005</xref>
###xml 3107 3129 3103 3125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Ota and Samelson, 1997</xref>
###xml 3237 3252 3233 3248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Fu et al., 1998</xref>
###xml 3509 3527 3501 3519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Saijo et al., 2003</xref>
###xml 3640 3662 3632 3654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Tsuruyama et al., 2002</xref>
###xml 3775 3776 3767 3768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Here, we demonstrate that pre-B cell receptor signaling suppresses proliferation of Ph+ ALL cells via up-regulation of IKAROS and IKAROS-mediated cell cycle arrest (Fig. 5). Specifically, upstream components of the pre-B cell receptor signaling complex, including the mu chain (Fig. 4) and SLP65 (Fig. 3), function as potent tumor suppressors and induce cell cycle exit through an IKAROS-dependent mechanism (Fig. 6 and Fig. 7). Consistent with a tumor suppressor role of the pre-B cell receptor, its function is compromised in most if not all cases of Ph+ ALL (Fig. 1). This raises the question how IKAROS can function as a tumor suppressor downstream of the pre-B cell receptor, if mu chain expression is compromised in most, if not all, cases of Ph+ ALL. In this respect, Ph+ ALL differs from other subtypes of ALL by its particularly high frequency of IKAROS deletions (>80%, Mullighan et al., 2008) and by the fact that Ph+ ALL is driven by a constitutively active tyrosine kinase (BCR-ABL1) that activates critical signaling molecules (SRC kinases, BTK, and CBL) downstream of the pre-B cell receptor (Hu et al., 2004; Ptasznik et al., 2004; Feldhahn et al., 2005). Here, we show that these two characteristics of Ph+ ALL are linked to each other because pre-B cell receptor signaling induced up-regulation of IKAROS (Fig. 6) and reconstitution of IKAROS redirects oncogenic BCR-ABL1 tyrosine kinase signaling from SRC kinase activation to SLP65 (Fig. 7 B), a critical tumor suppressor downstream of the pre-B cell receptor. We propose that even in the absence of a functional mu chain, IKAROS functions as a tumor suppressor in Ph+ ALL through its ability to divert oncogenic BCR-ABL1 kinase signaling to the pre-B cell receptor downstream linker molecule SLP65. According to this scenario, SLP65 is at the center of an IKAROS-dependent pathway of tumor suppression in Ph+ ALL (Fig. S1). Activation of SLP65 (phosphorylation at Y96) is either initiated from the pre-B cell receptor (mu chain, SYK; Fig. S1 A) or through IKAROS-mediated diversion of BCR-ABL1, when pre-B cell receptor signaling is compromised (Fig. S1 B). In both cases, SLP65, when phosphorylated at Y96 would inhibit STAT5-JAK3 signaling (Nakayama et al., 2009) and induce cell cycle arrest through up-regulation of IKAROS (Fig. 6) and p27 (CDKN1B; Gomez-del Arco et al., 2004; Kathrein et al., 2005). If both pre-B cell receptor and IKAROS signaling are compromised, however, this pathway of tumor suppression is inactivated (Fig. S1 C). In this case, SLP65 is no longer activated downstream of the pre-B cell receptor or through IKAROS-mediated rerouting of BCR-ABL1 kinase activity. Instead, BCR-ABL1 activates SRC kinases (LYN, HCK, and FGR; Hu et al., 2004; Ptasznik et al., 2004), BTK (Feldhahn et al., 2005) and STAT5-JAK3 (Ilaria and Van Etten., 1996), which promote oncogenic survival signaling (Ilaria and Van Etten, 1996; Hu et al., 2004; Ptasznik et al., 2004; Feldhahn et al., 2005). In addition, BCR-ABL1-mediated phosphorylation of LYN leads to activation of CBL, which ubiquitinates SYK for proteasomal degradation (Ota and Samelson, 1997; Fig. S1C). Because SYK kinase activity is required for activation of SLP65 (phosphorylation of SLP65-Y96; Fu et al., 1998), BCR-ABL1/LYN/CBL-induced proteasomal degradation of SYK also prevents further activation of the SLP65 tumor suppressor (Fig. S1 C). As a consequence, SRC kinase signaling downstream of BCR-ABL1 induces survival signaling through activation of NF-kappaB (Saijo et al., 2003; Fig. S1 C), whereas BCR-ABL1-mediated activation of STAT5-JAK3 induces proliferation via up-regulation of MYC (Tsuruyama et al., 2002; Fig. S1 C). Although our findings do not exclude other important functions of the IKAROS tumor suppressor in Ph+ ALL, we propose that IKAROS induces cell cycle arrest downstream of the pre-B cell receptor and also reroutes oncogenic BCR-ABL1 kinase activity into the pre-B cell receptor signaling pathway, even if signaling from the mu chain is compromised. Future experiments will focus on the mechanism through which IKAROS diverts BCR-ABL1 kinase activity from the SRC kinase pathway (survival, proliferation) to SYK/SLP65 (differentiation, cell cycle control).
###end p 39
###begin title 40
MATERIALS AND METHODS
###end title 40
###begin title 41

###end title 41
###begin title 42
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Patient samples, human cells, and cell lines.
###end title 42
###begin p 43
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 399 400 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 403 404 403 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
Normal human pro-B cells (CD19+ CD34+ VpreB-), pre-B cells (CD19+ CD34- VpreB+) and immature B cells (CD19+ CD10+ CD20+) were sorted from human bone marrow (from four healthy donors; Cambrex, Verviers, Belgium) by flow cytometry using antibodies from BD and a FACSVantage SE cell sorter (BD). Single cells from each population were sorted into PCR reaction tubes for single-cell PCR analysis of Ig VH-DJH gene rearrangements.
###end p 43
###begin p 44
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 178 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 181 182 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 608 609 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 565 572 <span type="species:ncbi:9606">patient</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
###xml 712 719 <span type="species:ncbi:9606">Patient</span>
###xml 1295 1300 <span type="species:ncbi:9606">human</span>
VH-DJH gene rearrangements were analyzed from 111 ALL cases, including 57 cases of Ph+ ALL and 54 cases of Ph-negative ALL. For 82 ALL cases, we amplified and sequenced clonal VH-DJH gene rearrangements from leukemia-derived cDNA, and for 9 cases, we reanalyzed primary data provided by M.J.S. Dyer (Institute of Cancer Research, Sutton, England, UK). For 10 additional cases of Ph+ ALL, sequence data from EMBL/GenBank/DDBJ (M.J. Brisco, Flinders University, Adelaide, Australia; accession nos. , , , -, ) were reanalyzed. Fresh leukemic blasts were isolated from patient-derived bone marrow samples with Ph+ ALL. Primary leukemia cells were cultured on OP9 stroma cells in the presence of 10 ng/ml human IL-7. Patient samples were provided from the Departments of Hematology and Oncology, University Hospital Benjamin Franklin, Berlin, Germany (W.K. Hoffman), the University of Bologna, Bologna, Italy (G. Martinelli), and the Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden (A. Li) and the USC Norris Comprehensive Cancer Center in compliance with Institutional Review Board regulations (approval from the Ethik-Kommission of the Charite, Campus Benjamin Franklin and the Internal Review Board of the University of Southern California Health Sciences Campus). The human ALL cell lines 380, 697, BV173, Kasumi-2, MHH-Call3, Nalm1, Nalm6, RCH-ACV, SD1, SEM, SUP-B15, and TOM1 were purchased from DSMZ.
###end p 44
###begin title 45
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 46 47 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
Single-cell PCR and sequence analysis of VH-DJH gene rearrangements.
###end title 45
###begin p 46
###xml 268 288 264 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">M&#252;schen et al., 2000</xref>
Single pro-, pre-, and immature B cells were FACS sorted into individual PCR reaction tubes containing 20 microl 1X PCR reaction buffer. Single cells were then digested using proteinase K and subjected to a whole-genome preamplification step, as previously described (Muschen et al., 2000). Aliquots from these reactions were used for two rounds of PCR amplification using the primer sets detailed in  in 35 and 45 cycles, respectively.
###end p 46
###begin title 47
SNP mapping assay for genomic deletions.
###end title 47
###begin p 48
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nsp</italic>
###xml 597 600 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nsp</italic>
Genomic DNA was extracted from 22 bone marrow Ph+ ALL samples, in which blast counts were >80%, using the DNA Blood Mini kit (QIAGEN) and quantified using a NanoDrop Spectrophotometer. The SNP mapping assay (Affymetrix) started with the digestion of 250 ng of DNA sample (NspI), followed by ligation of a common primer and amplification by PCR. The PCR conditions were optimized for the selective amplification of fragments that are 250-2,000 nt in length. The amplicons were fragmented by DNaseI digestion and labeled using TdT and a biotinylated nucleotide analogue, and then hybridized to 250K NspI arrays (Affymetrix). After washing and staining, the arrays were scanned for data analysis using the GeneChip Scanner 3000 (Affymetrix). CEL files were generated using GeneChip Genotyping Analysis Software (GTYPE) version 4.0. SNP calls were generated using GTYPE. Affymetrix CEL files were analyzed for genomic copy number variations using Partek Genomic Suite V and are available from GEO under accession no. . The underlying algorithm of CNAG strongly improves the signal-to-noise ratios of the final copy number output by correcting for length and GC content of the individual PCR products using quadratic regressions and by providing fully automated optimal sample selection. Copy number aberrations were scored using the Hidden Markow Model and by visual inspection. All aberrations were calculated with respect to a set of 48 HapMap normal individuals.
###end p 48
###begin title 49
Affymetrix GeneChip analysis.
###end title 49
###begin p 50
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1198 1199 1194 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 662 667 <span type="species:ncbi:10090">mouse</span>
###xml 1190 1195 <span type="species:ncbi:9606">human</span>
CD19+ AA4.1+ bone marrow B cell precursors were FACS sorted from each three wild-type, BCR-ABL1 transgenic, preleukemic mice with full-blown ALL and from leukemic mice after 7 d of treatment with the BCR-ABL1 kinase inhibitor AMN107. Total RNA from cells used for microarray or RT-PCR analysis was isolated by RNeasy (QIAGEN) purification. Double-strand complementary DNA was generated from 5 microg of total RNA using a poly(dT) oligonucleotide that contains a T7 RNA polymerase initiation site and the SuperScript III reverse transcription (Invitrogen). Biotinylated cRNA was generated and fragmented according to the Affymetrix protocol and hybridized to 430 mouse microarrays (Affymetrix). To determine relative signal intensities, the ratio of intensity for each sample in a probeset was calculated by normalizing to the mean value. Ratios were exported in Gene Cluster and visualized as a heat map with Java TreeView. Cel files from GeneChip arrays are available from GEO under accession no.  and were imported to the BRB Array Tool () and processed using the RMA algorithm (Robust Multi-Array Average) for normalization and summarization. Affymetrix U133A2.0 GeneChip data from four human Ph+ ALL cell lines (BV173, Nalm1, SUP-B15, and TOM1) generated by us are accessible through GEO accession .
###end p 50
###begin title 51
Quantitative RT-PCR analysis.
###end title 51
###begin p 52
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hprt</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ikaros</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
For quantitative RT-PCR analysis of human BCR-ABL1, mouse Hprt, Slp65, Ighm, and Ikaros, PCR primers are listed in Table S4. Quantitative real-time PCR performed with the SYBR GreenER mix (Invitrogen) was performed according to standard PCR conditions and an ABI7900HT (Applied Biosystems) real-time PCR system.
###end p 52
###begin title 53
BCR-ABL1 kinase inhibitors STI571 and AMN107.
###end title 53
###begin p 54
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
###xml 127 133 <span type="species:ncbi:3818">peanut</span>
###xml 222 228 <span type="species:ncbi:3818">peanut</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
STI571 and AMN107 were obtained from Novartis Pharmaceuticals. Leukemic BCR-ABL1 transgenic mice were fed a mixture of 8 parts peanut butter and 2 parts vegetable oil, with 75 mg of AMN107/kg body weight added to the same peanut/oil mixture daily. After 7 d of treatment, mice were sacrificed and leukemia cells were analyzed in the peripheral blood, bone marrow, and spleen.
###end p 54
###begin title 55
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
BCR-ABL1 transgenic mice.
###end title 55
###begin p 56
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 62 86 62 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Heisterkamp et al., 1990</xref>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 279 294 <span type="species:ncbi:10090">transgenic mice</span>
The BCR-ABL1 transgenic mouse model was described previously (Heisterkamp et al., 1990). In the C57BL/6J background, mean age at death for the f10-f15 generation (n = 127) was 100 d (range, 38-265 d). In the experiments described here, healthy and phenotypically normal BCR-ABL1 transgenic mice at an age <60 d were considered preleukemic.
###end p 56
###begin title 57
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Slp65-/- mice.
###end title 57
###begin p 58
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 162 180 162 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Jumaa et al., 1999</xref>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
Targeting of the Slp65 locus in BALB/c mice resulted in replacement of the Slp65 exon 4 by a Neomycin selection cassette in opposite transcriptional orientation (Jumaa et al., 1999). These mice lack expression of functional Slp65, but exhibit Neo-Slp65 fusion transcripts. Bone marrow-derived B cells from these mice are arrested at the pre-B cell stage of development and proliferated vigorously under cell culture conditions in the presence of 10 ng/ml mouse IL-7.
###end p 58
###begin title 59
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
Ighm-/- mice.
###end title 59
###begin p 60
###xml 316 320 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 320 323 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 399 403 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 403 406 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 491 496 <span type="species:ncbi:10090">mouse</span>
The transmembrane domain of the constant mu region was targeted in these mice (The Jackson Laboratory). B cell precursors in these mice can undergo V(D)J recombination of Ig variable genes, but they fail to express a mu chain on the cell surface and therefore lack pre-B cell receptor function. B cell precursors in Ighm-/- mice are arrested at the pro-B cell stage of development. Bone marrow from Ighm-/- mice was isolated and B cell precursors were propagated in the presence of 10 ng/ml mouse IL-7.
###end p 60
###begin title 61
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 36 <span type="species:ncbi:10090">transgenic mice</span>
Rag2-/- tTA/mu chain transgenic mice.
###end title 61
###begin p 62
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 38 55 37 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Hess et al., 2001</xref>
###xml 274 278 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 278 281 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 36 <span type="species:ncbi:10090">transgenic mice</span>
###xml 295 310 <span type="species:ncbi:10090">transgenic mice</span>
Rag2-/- tTA/mu chain transgenic mice (Hess et al., 2001) are unable to express an endogenous mu chain because they lack Rag2-dependent V(D)J recombination, but carry a functionally prerearranged mu chain under control of Tet operator sequences in the germline. In addition, Rag2-/- tTA/mu chain transgenic mice express a tTA under control of endogenous mu chain regulatory elements.
###end p 62
###begin title 63
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Reconstitution of pre-B cell receptor defects in Ph+ ALL and BCR-ABL1-transformed mouse ALL cells.
###end title 63
###begin p 64
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 133 150 132 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Pear et al., 1998</xref>
###xml 301 305 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag2</italic>
###xml 305 308 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 334 338 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 338 341 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 347 352 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 352 355 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 434 451 431 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Pear et al., 1998</xref>
###xml 532 547 529 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Li et al., 1999</xref>
###xml 605 609 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ighm</italic>
###xml 609 612 606 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 766 771 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 771 774 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 133 137 <span type="species:ncbi:23211">Pear</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:23211">Pear</span>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
###xml 715 720 <span type="species:ncbi:10090">mouse</span>
###xml 862 868 <span type="species:ncbi:10090">murine</span>
Human Ph+ ALL cells lacking mu chain, SLP65 or IKAROS expression were transduced with retroviral vectors (MSCV backbone described in Pear et al., 1998) encoding a functional mu chain/CD8, the active IKAROS form IK1/GFP or SLP65/GFP. CD8 and GFP empty vector controls were used. Bone marrow cells from Rag2-/- tTA/mu chain transgenic, Ighm-/-, and Slp65-/- mice were transduced with retroviral vectors encoding p190 and p210 BCR-ABL1 (Pear et al., 1998) in the presence of 10 ng/ml IL-7, which results in the outgrowth of pre-B ALL (Li et al., 1999). After transformation, IL-7 was no longer supplemented. Ighm-/- ALL cells were transduced with retroviral constructs encoding mouse CD8 alone or CD8 and a functional mouse mu chain. In a different set of experiments, Slp65-/- ALL cells were transduced with a retroviral vector encoding GFP alone (GFP), wild-type murine Slp65 (Slp65/GFP), and mutant Slp65Y96F (Slp65Y96F/GFP) and GFP. In a loss-of-function analysis for IKAROS, IK6 a dominant-negative form of IKAROS was overexpressed (IK6/GFP) using a GFP empty vector control (GFP).
###end p 64
###begin title 65
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Inducible reconstitution of Slp65 in Slp65-/- BCR-ABL1-transformed pre-B ALL cells.
###end title 65
###begin p 66
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 193 218 193 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Meixlsperger et al., 2007</xref>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
To test the effect of Slp65-reconstitution on Slp65-/- BCR-ABL1-transformed pre-B ALL cells using an inducible model, we fused the Slp65 to the mutated estrogen receptor ligand-binding domain (Meixlsperger et al., 2007). Either ERT2 fused to the N terminus of Slp65 (ERT2-Slp65/GFP) or ERT2 alone (ERT2/GFP) were expressed in the Slp65-/- BCR-ABL1-transformed pre-B ALL cells. Addition of 1 mumol/l 4-hydroxy-tamoxifen dissolved in ethanol resulted in full activation of ERT2-Slp65 fusion molecules. Ethanol was used as a vehicle control.
###end p 66
###begin title 67
In vivo model for BCR-ABL1-transformed ALL and bioluminescence imaging.
###end title 67
###begin p 68
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 82 90 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 166 174 166 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slp65</italic>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
###xml 773 777 <span type="species:ncbi:10090">Mice</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
###xml 1003 1007 <span type="species:ncbi:10090">Mice</span>
###xml 1180 1185 <span type="species:ncbi:10090">mouse</span>
Pre-B cells from Slp65-/- mice were transformed with a retroviral vector encoding BCR-ABL1 and labeled with lentiviral firefly luciferase. After luciferase-labeling, BCR-ABL1-transformed pre-B cells were transduced with retroviral vectors encoding either GFP or Slp65/GFP, and 3 x 106 GFP+ cells were injected into sublethally irradiated (250 cGy) NOD/SCID. After the injection of cells, the mice were imaged at different time points using an in vivo IVIS 100 bioluminescence/optical imaging system (Xenogen). D-Luciferin (Xenogen) dissolved in PBS was injected i.p. at a dose of 2.5 mg per mouse 15 min before measuring the light emission. General anesthesia was induced with 5% isoflurane and continued during the procedure with 2% isoflurane introduced via a nose cone. Mice were monitored by bioimaging on a weekly basis and also monitored for weight loss and other signs of disease. When the first mice became terminally ill because of leukemia, all mice in the ongoing experiment were sacrificed. Mice were studied for potential enlargement of the spleen and bone marrow, spleen, and peripheral blood were analyzed by flow cytometry to quantitate leukemic infiltration. All mouse experiments were subject to institutional approval by Childrens Hospital Los Angeles Institutional Animal Care and Use Committee.
###end p 68
###begin title 69
Clonality analysis and spectratyping of B cell populations.
###end title 69
###begin p 70
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
VH-DJH gene rearrangements from B cell populations were amplified using PCR primers specific for the J558 VH region gene together with a primer specific for the Cmu constant region gene. Using a FAM-labeled Cmu constant region gene-specific primer in a run-off reaction, PCR products were labeled and subsequently analyzed on an ABI3100 capillary sequencer by fragment length analysis. Sequences of primers used are given in Table S4.
###end p 70
###begin title 71
Flow cytometry and cell cycle analysis.
###end title 71
###begin p 72
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 269 277 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1155 1156 1129 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
Peripheral blood, spleen, and bone marrow samples from C57BL/6 mice and BCR-ABL1 transgenic mice were stained using FACS antibodies against CD19, CD23, B220, kappa and lambda light chains, IL-7ralpha, mu chain and AA4.1 (antibodies from BD). For cell cycle analysis in BCR-ABL1 ALL cells, the BrdU flow cytometry kit for cell cycle analysis (BD) was used according to manufacturer's instructions. BrDU incorporation (APC-labeled anti-BrdU antibodies) was measured together with DNA content (7-amino-actinomycin-D) in fixed and permeabilized cells. The analysis was either gated on viable cells that were identified either based on scatter morphology or GFP or IK6/GFP expression. Because individual experiments showed variations, means of percentages of cells in G0/G1, S and G2/M phase were calculated and depicted as box plots. The leukemia cells studied here have a cell cycle duration of approximately48 h (estimate based on cell culture growth kinetics). Long incubation of the cells in BrdU may lead to an overestimate of the fraction of cells in cycle, because cells that incorporated BrdU during the incubation with the nucleotide will remain BrdU+ even after the cells returned into the G0/G1 phase of the cell cycle. For this reason, BrdU-incubation was limited to 30 min as recommended by the manufacturer.
###end p 72
###begin title 73
Western blot.
###end title 73
###begin p 74
Polyclonal antibodies against LYN, SRC phospho-Y416, CBL, CBL phospho-Y731, SLP65, SLP65 phospho-Y96, and a monoclonal antibody against EIF4E (C46H6) were purchased from Cell Signaling Technologies. Western blot analysis was performed using the Western breeze kit (Invitrogen). Imatinib (Gleevec, STI571) was a gift from Novartis.
###end p 74
###begin title 75
###xml 17 19 17 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
Measurement of Ca2+ release in response to pre-B cell receptor engagement.
###end title 75
###begin p 76
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 312 314 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 129 134 <span type="species:ncbi:9606">Human</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 230 235 <span type="species:ncbi:9606">human</span>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
CD19+ cells from peripheral blood and bone marrow of healthy donors were purified using immunomagnetic beads (Miltenyi Biotech). Human and mouse B cell and ALL populations were treated with antibodies specific for the mu chain of human (Jackson ImmunoResearch Laboratories) and mouse (SouthernBiotech) origin. Ca2+ release from cytoplasmic stores in response to (pre-) B cell receptor engagement was measured by loading of the cells with the lipophilic Fluo-4 dye (Invitrogen).
###end p 76
###begin title 77
Online supplemental material.
###end title 77
###begin p 78
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGHM</italic>
###xml 700 703 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 752 760 752 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR-ABL1</italic>
###xml 1028 1029 1028 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1155 1172 1155 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Ross et al., 2003</xref>
###xml 1174 1195 1174 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">van Zelm et al., 2005</xref>
###xml 1219 1227 1219 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1281 1287 1281 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VPREB1</italic>
###xml 1308 1309 1308 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 462 477 <span type="species:ncbi:10090">transgenic mice</span>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
Table S1 presents the amino acid translation of the IGHM VDJ junction sequence of single sorted pro- and pre-B cells and immature B cells from healthy donors (A) and 57 cases of Ph+ ALL (B). Table S1 also includes a description of our statistical model for the comparison of functional versus nonfunctional IGHM V-DJ gene rearrangements. Table S2 presents data on white blood counts, counts of peripheral blood B cell precursors, and splenic weights in BCR-ABL1 transgenic mice during progressive transformation. Table S3 presents data on white blood counts, counts of peripheral blood B cell precursors, and splenic weights in a different mouse model, in which NOD/SCID mice were injected with SLP65-/- pre-B cells that were transformed by retroviral BCR-ABL1. Table S4 presents a summary of oligonucleotides used for single-cell PCR, quantitative RT-PCR and Ig spectratyping. Fig. S1 presents a schematic rendition of our scenario for the cooperation between pre-B cell receptor signaling and IKAROS as tumor suppressors in Ph+ ALL. Fig. S2 presents details of our normalization algorithm and comparison of two previously published microarray analyses (Ross et al., 2003; van Zelm et al., 2005) in one meta-analysis (Fig. 1 C). Fig. S3 shows experimental data on verification of VPREB1 gene deletions in Ph+ ALL by FISH and genomic quantitative PCR. Online supplemental material is available at .
###end p 78
###begin title 79
Supplementary Material
###end title 79
###begin title 80
[Supplemental Material]
###end title 80
###begin p 81
###xml 224 226 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We would like to thank Dr. Alan M. Gewirtz for encouragement and discussions, Dr. Niklas Feldhahn, and Dr. Ravi Bhatia for critical discussions. We are indebted to Mi Sook Chang for help with IK6 analyses, Neda Roosta for Ca2+ measurements, Natalya Perelman for Western blot analyses, and Nina Horwege for flow cytometry of primary Ph+ ALL cells.
###end p 81
###begin p 82
This work is supported by grants from the Leukemia and Lymphoma Society (to M. M.), the Alex's Lemonade Stand Foundation for Pediatric Cancer Research (M. Muschen), The V Foundation for Cancer Research (M. Muschen and Y.M. Kim), National Institutes of Health R01CA090321 (N. Heisterkamp), R01CA137060 (M. Muschen), R01CA139032 (M. Muschen), T32 CA009659-16 (Y. DeClerck), and The Kenneth T. and Eileen L. Norris Foundation (J. Groffen and M. Muschen).
###end p 82
###begin p 83
The authors have no conflicting financial interests.
###end p 83
###begin article-title 84
Phosphorylation of Bruton's tyrosine kinase by c-Abl.
###end article-title 84
###begin article-title 85
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Syk tyrosine kinase required for mouse viability and B-cell development.
###end article-title 85
###begin article-title 86
Jak-STAT signaling induced by the v-abl oncogene.
###end article-title 86
###begin article-title 87
Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells.
###end article-title 87
###begin article-title 88
The adaptor protein SLP65 acts as a tumor suppressor that limits pre-B cell expansion.
###end article-title 88
###begin article-title 89
BLNK: a central linker protein in B cell activation.
###end article-title 89
###begin article-title 90
Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition.
###end article-title 90
###begin article-title 91
###xml 18 23 <span type="species:ncbi:9606">human</span>
Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex.
###end article-title 91
###begin article-title 92
The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells.
###end article-title 92
###begin article-title 93
Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors.
###end article-title 93
###begin article-title 94
###xml 27 42 <span type="species:ncbi:10090">transgenic mice</span>
Acute leukaemia in bcr/abl transgenic mice.
###end article-title 94
###begin article-title 95
Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells.
###end article-title 95
###begin article-title 96
Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor.
###end article-title 96
###begin article-title 97
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
###end article-title 97
###begin article-title 98
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
###end article-title 98
###begin article-title 99
P210 and P190BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.
###end article-title 99
###begin article-title 100
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65.
###end article-title 100
###begin article-title 101
Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.
###end article-title 101
###begin article-title 102
Ikaros induces quiescence and T-cell differentiation in a leukemia cell line.
###end article-title 102
###begin article-title 103
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.
###end article-title 103
###begin article-title 104
The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
###end article-title 104
###begin article-title 105
BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
###end article-title 105
###begin article-title 106
###xml 114 118 <span type="species:ncbi:10090">mice</span>
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
###end article-title 106
###begin article-title 107
Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.
###end article-title 107
###begin article-title 108
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.
###end article-title 108
###begin article-title 109
Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor.
###end article-title 109
###begin article-title 110
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
###end article-title 110
###begin article-title 111
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
###end article-title 111
###begin article-title 112
Rare occurrence of classical Hodgkin's disease as a T cell lymphoma.
###end article-title 112
###begin article-title 113
BLNK suppresses pre-B cell leukemogenesis through inhibition of JAK3.
###end article-title 113
###begin article-title 114
Ikaros has a crucial role in regulation of B cell receptor signaling.
###end article-title 114
###begin article-title 115
The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase.
###end article-title 115
###begin article-title 116
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
###end article-title 116
###begin article-title 117
Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells.
###end article-title 117
###begin article-title 118
Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros.
###end article-title 118
###begin article-title 119
Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment.
###end article-title 119
###begin article-title 120
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling.
###end article-title 120
###begin article-title 121
Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development.
###end article-title 121
###begin article-title 122
Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
###end article-title 122
###begin article-title 123
Redundancy in B cell developmental pathways: c-Cbl inactivation rescues early B cell development through a B cell linker protein-independent pathway.
###end article-title 123
###begin article-title 124
###xml 65 70 <span type="species:ncbi:9606">human</span>
The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells.
###end article-title 124
###begin article-title 125
Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits.
###end article-title 125
###begin article-title 126
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice.
###end article-title 126
###begin article-title 127
Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
###end article-title 127
###begin article-title 128
###xml 51 56 <span type="species:ncbi:9606">human</span>
Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression.
###end article-title 128
###begin p 129
Abbreviations used: ALL, acute lymphoblastic leukemia; DN, dominant-negative; IGHM, Ig mu heavy chain; mRNA, messenger RNA; Ph, Philadelphia chromosome; Tet, tetracycline; tTA, Tet-controlled transactivatore.
###end p 129

